 SOUTH SAN FRANCISCO, Calif., Nov. 02, 2022 GLOBE NEWSWIRE -- Nkarta, Inc. Nasdaq: NKTX, a biopharmaceutical company developing engineered natural killer NK cell therapies to treat cancer, today announced its participation at three upcoming investor conferences: 